In weight loss care, semaglutide may help patients: Feel full sooner Stay full longer Experience fewer cravings Reduce frequent snacking Improve portion control Build more consistent eating patterns The FDA-approved Wegovy prescribing information describes semaglutide as an option for chronic weight management when used with a reduced-calorie diet and increased physical activity in eligible patients
[7] If a patient has been inadvertently blunting alendronate absorption through poor supplement timing, a DXA at the two-year mark showing no improvement (or bone loss) should prompt a full medication and supplement review
While Topamax alone is not FDA-approved for weight loss, it is a key component of the FDA-approved combination drug, Qsymia, which includes topiramate and phentermine, a prescription appetite suppressant
A smaller subset of patients report fatigue and constipation during the first two weeks
Many patients report reduced appetite and fewer cravings around this time
A decrease in pup survival was seen at all doses